# Interlink Electronics Inc: Form 10-Q for the period ended Sep 30, 2020

- Company: [Interlink Electronics Inc](/companies/link.md) (CIK 828146)
- Form: 10-Q
- Filed: 2020-11-13
- Accepted by EDGAR: Nov 12, 2020, 19:44 ET
- Period: 2020-09-30
- Accession: 0001104659-20-124555
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/828146/000110465920124555/tm2035364d1_10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/828146/000110465920124555/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2020-07-01 to 2020-09-30 | $1.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months, 2020-01-01 to 2020-09-30 | $4.9m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2020-07-01 to 2020-09-30 | $737.0k | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2020-01-01 to 2020-09-30 | $2.2m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2020-07-01 to 2020-09-30 | $811.0k | us-gaap:GrossProfit |
| Gross profit | 9 months, 2020-01-01 to 2020-09-30 | $2.8m | us-gaap:GrossProfit |
| Research and development | 3 months, 2020-07-01 to 2020-09-30 | $208.0k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2020-01-01 to 2020-09-30 | $786.0k | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2020-07-01 to 2020-09-30 | $682.0k | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2020-01-01 to 2020-09-30 | $2.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2020-07-01 to 2020-09-30 | −$79.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2020-01-01 to 2020-09-30 | −$110.0k | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2020-07-01 to 2020-09-30 | −$185.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2020-01-01 to 2020-09-30 | −$213.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2020-07-01 to 2020-09-30 | $65.0k | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2020-01-01 to 2020-09-30 | $60.0k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2020-07-01 to 2020-09-30 | $0.01 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 9 months, 2020-01-01 to 2020-09-30 | $0.01 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted shares (weighted) | 3 months, 2020-07-01 to 2020-09-30 | 6,601,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2020-01-01 to 2020-09-30 | 6,598,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2020-01-01 to 2020-09-30 | $42.0k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | at 2020-09-30 | $6.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-09-30 | $8.4m | us-gaap:AssetsCurrent |
| Total assets | at 2020-09-30 | $10.0m | us-gaap:Assets |
| Current liabilities | at 2020-09-30 | $1.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2020-09-30 | $1.3m | us-gaap:Liabilities |
| Short-term borrowings | at 2020-09-30 | $186.0k | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2020-09-30 | $8.7m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 29,402 characters.

*This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The words “believe,” “may,” “will,” “potentially,” “estimate,” “continue,” “anticipate,” “intend,” “could,” “would,” “project,” “plan,” “expect” and similar expressions that convey uncertainty of future events or outcomes are intended to identify forward-looking statements.These forward-looking statements speak only as of the date of this Form 10-Q and are subject to uncertainties, assumptions and business and economic risks. As such, our actual results could differ materially from those set forth in the forward-looking statements as a result of the factors set forth below in Part II, Item 1A, “Risk Factors,” and in our other reports filed with the Securities and Exchange Commission. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we cannot guarantee that the future results, levels of activity, performance or events and circumstances described in the forward-looking statements will be achieved or occur. We undertake no obligation to update publicly any forward-looking statements for any reason after the date of this Form 10-Q to conform these statements to actual results or to changes in our expectations, except as required by law.*

*The following discussion should be read in conjunction with our unaudited condensed consolidated financial statements and notes thereto appearing elsewhere in this Quarterly Report on Form 10-Q with the understanding that our actual future results, levels of activity, performance and events and circumstances may be materially different from what we expect.*

### Overview

Interlink Electronics Inc. (“we”, “us”, “our”, “Interlink” or the “Company”) designs, develops, manufactures and sells a range of force-sensing technologies that incorporate our proprietary materials technology, firmware and software into a portfolio of standard products and custom solutions. These include sensor components, subassemblies, modules and products that support effective, efficient cursor control and novel three-dimensional user inputs. Our Human Machine Interface (“HMI”) technology platforms are deployed in a wide range of markets including consumer electronics, automotive, industrial, and medical. The application of our HMI technology platforms includes vehicle entry, vehicle multi-media control interface, rugged touch controls, presence detection, collision detection, speed and torque controls, biological monitoring and others.

Interlink has been a leader in the printed electronics industry for over 30 years with the commercialization of our patented Force-Sensing Resistor (“FSR®”) technology that has enabled rugged and reliable HMI solutions. Our solutions have focused on handheld user input, menu navigation, cursor control, and other intuitive interface technologies for the world’s top electronics manufacturers.

We invented FSR® technology and pioneered commercialization of printed electronics manufacturing, paving the way for industry-wide adoption of force sensing technology. Our extensive knowledge and experience with this technology, along with the firmware we incorporate in our HMI solutions, differentiates us from other providers of HMI solutions. We, along with our customers, incorporate our FSR and force sensing sensors and modules into end user products. Our sensors and modules are used in electronics devices and systems where user input must be converted into useful output data. Our force sensing technology solution platforms enabled industry-first implementations in gaming, smartphone, rugged notebook, automotive cockpit and automotive entry applications. Consumer and end-user demand for enhanced user experience is driving the need for innovative multi-modal HMI technologies and applications. Force sensing input provides a critical novel modality that drives a paradigm shift in HMI.

Market requirements for innovative solutions that enable smaller, thinner devices, lower power consumption, highly refined designs, better navigation and more intuitive usability in all environments, are also driving increased demand for our products. Industry is moving towards the use of multi-modal HMI in the home, industrial, medical and automotive spaces. Interlink delivers cutting edge, high performance HMI solutions for customers who wish to replace outdated switches and knobs in these environments.

Significant market opportunities are rapidly emerging for us to improve upon the functionality of standard capacitive sensors which are widely available and competitively priced. Inadvertent activation, where users unintentionally activate a control, is a common problem with capacitive technology. In contrast, force sensing solutions require a deliberate application of force to operate. We have had recent success in using our force sensing solutions in combination with capacitive technologies to minimize the latter’s performance issues, enabling force sensing solutions to complement competitive technologies and provide hybrid solutions and open up new opportunities for growth. We continue to simultaneously expand our standard product portfolio and develop new technology platforms to grow existing markets and capture emerging markets. This portfolio expansion will incorporate other complimentary sensing technologies. This broader portfolio of technologies will allow us to use our expertise in integrating multiple sensing technologies for applications in the rapidly growing Internet-of-Things (“IoT”).

Interlink serves our world-wide customer base from our corporate headquarters in Irvine, California (Orange County area) and from our facility in Camarillo, California (Ventura County). We plan to establish a Global Product Development and Materials Science Center in our existing Camarillo footprint, which we expect to be operational by early 2021. This facility will have a state-of-the-art printed electronics development laboratory as well as materials science lab. Our engineering team will be based in this center where we will work with our US and global customers on developing, engineering, prototyping and implementing our advanced HMI solutions. We also maintain a small embedded software and IoT application development center in Singapore. We manufacture all our products in our printed electronics manufacturing facility in Shenzhen, China, which has been in operation since 2006. In addition, we maintain a global distribution and logistics center in Hong Kong, a technical sales office in Japan, and several manufacturer representatives and distributors in strategic locations in our key markets, all of which allows us to support our global customer base. We sell our products in a wide range of markets, including consumer electronics, automotive, industrial and medical. Our customers are some of the world’s largest companies and most recognizable brands.

### Critical Accounting Policies and Estimates

We prepare our consolidated financial statements in accordance with generally accepted accounting principles in the United States (“GAAP”). The preparation of consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses, and related disclosures. We evaluate our estimates and assumptions on an ongoing basis. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ significantly from the estimates made by our management. To the extent that there are differences between our estimates and actual results, our future financial statements presentation, financial condition, results of operations, and cash flows will be affected.

A description of our critical accounting policies that represent the more significant judgments and estimates used in the preparation of our financial statements was provided in the Management’s Discussion and Analysis of Financial Condition and Results of Operations section in our Amendment No. 2 to Registration Statement on Form 10 filed with the Securities and Exchange Commission on September 29, 2020. There have been no changes to our critical accounting policies and estimates described in the Form 10 that have had a material impact on our condensed consolidated financial statements and related notes.

### Recently Issued and Adopted Accounting Pronouncements

Recent accounting pronouncements are detailed in Note 1 to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.

### Results of Operations

The following table sets forth certain unaudited condensed consolidated statements of income data for the periods indicated. The percentages in the table are based on net revenues.

*(in thousands, except percentages)*

*(in thousands, except percentages)*

|  | Three months ended September 30, 2020 $% |  | 2019 $% |  | Nine months ended September 30, 2020 $% |  | 2019 $% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue, net | $1,548 | 100.0% | $2,157 | 100.0% | $4,941 | 100.0% | $5,613 | 100.0% |
| Cost of revenue | 737 | 47.6% | 1,076 | 49.9% | 2,173 | 44.0% | 2,779 | 49.5% |
| Gross profit | 811 | 52.4% | 1,081 | 50.1% | 2,768 | 56.0% | 2,834 | 50.5% |
| Operating expenses: |  |  |  |  |  |  |  |  |
| Engineering, research and development | 208 | 13.4% | 292 | 13.5% | 786 | 15.9% | 632 | 11.3% |
| Selling, general and administrative | 682 | 44.1% | 586 | 27.2% | 2,092 | 42.3% | 1,971 | 35.1% |
| Total operating expenses | 890 | 57.5% | 878 | 40.7% | 2,878 | 58.2% | 2,603 | 46.4% |
| Income (loss) from operations | (79) | (5.1)% | 203 | 9.4% | (110) | (2.2)% | 231 | 4.1% |
| Other income (expense): |  |  |  |  |  |  |  |  |
| Other income (expense), net | (41) | (2.7)% | 25 | 1.2% | (43) | (0.9)% | 49 | 0.9% |
| Income (loss) before income taxes | (120) | (7.8)% | 228 | 10.6% | (153) | (3.1)% | 280 | 5.0% |
| Income tax expense (benefit) | (185) | (12.0)% | 117 | 5.4% | (213) | (4.3)% | 374 | 6.7% |
| Net income (loss) | $65 | 4.2% | $111 | 5.1% | $60 | 1.2% | $(94) | (1.7)% |
| Other comprehensive income, net of tax: |  |  |  |  |  |  |  |  |
| Foreign currency translation adjustments | 64 | 4.1% | (44) | (2.0)% | 49 | 1.0% | (49) | (0.9)% |
| Comprehensive income (loss) | $129 | 8.3% | $67 | 3.1% | $109 | 2.2% | $(143) | (2.5)% |

### Comparison of Three Months Ended September 30, 2020 and 2019

Revenue, net by Market is as follows:

*(in thousands, except percentages)*

|  | Three months ended September 30, 2020 Amount | % of Net Revenue | 2019 Amount | % of Net Revenue | Change | % Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Industrial | $319 | 20.6% | $481 | 22.3% | $(162) | (33.7)% |
| Medical | 16 | 1.0% | 845 | 39.1% | (829) | (98.1)% |
| Consumer | 374 | 24.2% | 75 | 3.5% | 299 | 398.7% |
| Standard | 839 | 54.2% | 756 | 35.1% | 83 | 11.0% |
| Revenue, net | $1,548 | 100.0% | $2,157 | 100.0% | $(609) | (28.2)% |

We sell our custom products into the industrial, medical and consumer markets. We previously sold custom products in the automotive market and continue to peruse opportunities in that sector. We sell our standard products through various distribution networks. The ultimate customer for standards products may come from different markets which are often unknown to us at the time of sale. Each market has different product design cycles. Products with longer design cycles often have much longer product life-cycles. Automotive, industrial, and medical products generally have longer design and life-cycles than consumer products. We currently have products with life-cycles that have exceeded twenty years and are ongoing.

Overall revenues for the three months ended September 30, 2020 decreased 28.2% as compared to the prior year period due to lower demand from our medical customer as COVID-19 affected their planned manufacturing cycle, and decreased volume of purchases by our industrial customers. These decreases were partially offset by increased demand from our consumer customer. The timing of orders from our customers is not always predictable and can be concentrated in varying periods during the year to coincide with their project and building plans. Many of our products are currently subject to import tariffs imposed on goods manufactured in China, increasing the cost to our customers.

Some of our more recent custom product success for new product lines in the medical market is making its way into the pipeline as part of a long design cycle and revenues are being realized. Overall, we expect revenues to stabilize for the remainder of the year.

*(in thousands, except percentages)*

|  | Three months ended September 30, 2020 Amount | % of Net Revenue | 2019 Amount | % of Net Revenue | Change | % Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cost of revenue | $737 | 47.6% | $1,076 | 49.9% | $(339) | (31.5)% |

Our cost of revenue is impacted by various factors including product mix, volume, material costs, manufacturing efficiencies, facilities costs, compensation costs and any provisions for excess and obsolete inventories. Cost of revenues decreased for the three months ended September 30, 2020 as compared with the prior year period as revenues decreased, and as a result of product mix, as well as improved efficiencies at our China facility. Gross margin improved to 52.4% for the three months ended September 30, 2020, as compared to 50.1% for the three months ended September 30, 2019. Cost of revenue and gross margin were adversely affected by the costs of import tariffs imposed on goods manufactured in China.

*(in thousands, except percentages)*

|  | Three months ended September 30, 2020 Amount | % of Net Revenue | 2019 Amount | % of Net Revenue | Change | % Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Engineering, research and development | $208 | 13.4% | $292 | 13.5% | $(84) | (28.8)% |

Engineering and R&D expenses consist primarily of compensation expenses for employees engaged in research, design and development activities. Our R&D team focuses both on internal design development, as well as design development aimed at addressing customer design challenges, in order to develop our HMI solutions.

Our engineering and R&D costs were lower during the three months ended September 30, 2020 as compared with the same period in the prior year due primarily to reduced costs and headcount at our Singapore R&D center as part of the transfer of the lab to Camarillo, CA.

*(in thousands, except percentages)*

|  | Three months ended September 30, 2020 Amount | % of Net Revenue | 2019 Amount | % of Net Revenue | Change | % Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Selling, general and administrative | $682 | 44.1% | $586 | 27.2% | $96 | 16.4% |

Selling, general and administrative expenses consist primarily of compensation expenses, legal and other professional fees, facilities expenses and communication expenses. The major factor in the increase in selling, general and administrative expense during the three months ended September 30, 2020 is due to the costs associated with the submission of a Registration Statement on Form 10 during the period. Sales and marketing costs also increased for the three months ended September 30, 2020 as compared to the comparable period of 2019 as a result of the Company building its sales and marketing team. We expect to incur additional selling, general and administrative expenses as we expand our geographic footprint and now that we are once again a public reporting company. Although there may be a lag, we expect increases in global revenue to more than offset these new costs.

*(in thousands, except percentages)*

|  | Three months ended September 30, 2020 Amount | % of Pre-tax Income | 2019 Amount | % of Pre-tax Income | Change | % Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Income tax expense (benefit) | $(185) | 154.2% | $117 | 51.3% | $(302) | (258.1)% |

Tax expense reflects statutory tax rates in the jurisdictions in which we operate adjusted for book/tax differences. Tax benefit for 2020 reflects the relative proportions of international net income and domestic loss.

Our effective tax rate is directly affected by the relative proportions of revenue and income before taxes in the jurisdictions in which we operate. Based on the expected mix of domestic and foreign earnings, we anticipate our effective tax rate to remain similar to the US statutory rate of 21% primarily due to a significant portion of our earnings originating in the higher rate China jurisdiction (25%), offset by lower rate jurisdictions in Singapore (17%) and Hong Kong (16.5%). State taxes also have an impact in the United States.

Discrete tax events may cause our effective rate to fluctuate on a quarterly basis. Certain events, including, for example, acquisitions and other business changes, which are difficult to predict, may also cause our effective tax rate to fluctuate. We are subject to changing tax laws, regulations, and interpretations in multiple jurisdictions. Continued corporate tax reform continues to be a priority in the U.S. and other jurisdictions. Additional changes to the tax system in the U.S. could have significant effects, positive and negative, on our effective tax rate, and on our deferred tax assets and liabilities.

### Comparison of Nine Months Ended September 30, 2020 and 2019

Revenue, net by Market is as follows:

*(in thousands, except percentages)*

|  | Nine months ended September 30, 2020 Amount | % of Net Revenue | 2019 Amount | % of Net Revenue | Change | % Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Industrial | $1,204 | 24.4% | $1,498 | 26.7% | $(294) | (19.6)% |
| Medical | 540 | 10.9% | 1,991 | 35.5% | (1,451) | (72.9)% |
| Consumer | 823 | 16.7% | 254 | 4.5% | 569 | 224.0% |
| Standard | 2,374 | 48.0% | 1,870 | 33.3% | 504 | 27.0% |
| Revenue, net | $4,941 | 100.0% | $5,613 | 100.0% | $(672) | (12.0)% |

Overall revenues for the nine months ended September 30, 2020 decreased 12.0% as compared to the prior year period due to lower demand from our medical customer as COVID-19 affected their planned manufacturing cycle, and decreased volume of purchases by our industrial customers. These decreases were partially offset by the timing of a standard product order from a longtime customer and increased demand from our consumer products customer. In the normal cycle, some of our larger customers purchase in bulk quantities and absorption of these products can straddle several financial reporting periods. The timing of orders from our customers is not always predictable and can be concentrated in varying periods during the year to coincide with their project and building plans. Many of our products are currently subject to import tariffs imposed on goods manufactured in China, increasing the cost to our customers.

*(in thousands, except percentages)*

|  | Nine months ended September 30, 2020 Amount | % of Net Revenue | 2019 Amount | % of Net Revenue | Change | % Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cost of revenue | $2,173 | 44.0% | $2,779 | 49.5% | $(606) | (21.8)% |

Cost of revenues decreased for the nine months ended September 30, 2020 as compared with the prior year period as revenues decreased, and as a result of product mix, as well as improved efficiencies at our China facility. Gross profit improved to 56.0% for the nine months ended September 30, 2020, as compared to 50.5% for the nine months ended September 30, 2019. Cost of revenue and gross margin were adversely affected by the costs of import tariffs imposed on goods manufactured in China.

*(in thousands, except percentages)*

|  | Nine months ended September 30, 2020 Amount | % of Net Revenue | 2019 Amount | % of Net Revenue | Change | % Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Engineering, research and development | $786 | 15.9% | $632 | 11.3% | $154 | 24.4% |

Our engineering and R&D costs were higher during the nine months ended September 30, 2020 as compared with the same period in the prior year primarily due to research incentive grant from the Singapore government paid last year in the quarter ended June 30, 2019.

*(in thousands, except percentages)*

|  | Nine months ended September 30, 2020 Amount | % of Net Revenue | 2019 Amount | % of Net Revenue | Change | % Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Selling, general and administrative | $2,092 | 42.3% | $1,971 | 35.1% | $121 | 6.1% |

A major factor in the increase in selling, general and administrative expense during the nine months ended September 30, 2020 is due to the costs associated with the submission of a Registration Statement on Form 10 during the period. Sales and marketing costs also increased for the nine months ended September 30, 2020 as compared to the comparable period of 2019 as a result of the Company building its sales and marketing team.

*(in thousands, except percentages)*

|  | Nine months ended September 30, 2020 Amount | % of Pre-tax Income | 2019 Amount | % of Pre-tax Income | Change | % Change |
| --- | ---: | ---: | ---: | ---: | ---: | --- |
| Income tax expense (benefit) | $(213) | 139.2% | $374 | 133.6% | $(587) | N/A% |

Tax benefit reflects statutory tax rates in the jurisdictions that we operate adjusted for book/tax differences. The tax benefit for the nine months ended September 30, 2020 was a result of the mix of domestic and foreign earnings. Tax expense for 2019 was higher primarily as a result of withholding tax on dividends paid by a subsidiary to our U.S.-based parent company.

### Liquidity and Capital Resources

Cash requirements for working capital and capital expenditures have been funded from cash balances on hand and cash generated from operations. As of September 30, 2020, we had cash and cash equivalents of $6.1 million, working capital of $7.3 million and no indebtedness except for a loan of $185 thousand we received from Silicon Valley Bank pursuant to the Paycheck Protection Program, which can be forgiven based upon the terms of that program. Cash and cash equivalents consist of cash and money market funds. We did not have any short-term or long-term investments as of September 30, 2020. Of the $6.1 million of cash balances on hand, $1.7 million was held by foreign subsidiaries. If these funds are needed for our operations in the U.S., we have several methods to repatriate without significant tax effects, including repayment of intercompany loans or distributions of previously taxed income. Other distributions may require us to incur U.S. or foreign taxes to repatriate these funds. However, our intent is to permanently reinvest these funds outside the U.S. and our current plans do not demonstrate a need to repatriate cash to fund our U.S. operations.

The Company received a loan from Silicon Valley Bank in the aggregate principal amount of $185 thousand pursuant to the Paycheck Protection Program (the “PPP”) under the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”), which was enacted March 27, 2020. The loan is evidenced by a promissory note, dated April 21, 2020, issued by us to the lender, which note matures on April 20, 2022, and bears interest at a rate of 1.00% per annum, payable monthly commencing on November 21, 2020, following an initial deferral period as specified under the PPP. We may prepay the note at any time prior to maturity with no prepayment penalties. Proceeds from the loan will be used to fund designated expenses, including certain payroll costs, group health care benefits and other permitted expenses, in accordance with the PPP. Under the terms of the PPP, up to the entire amount of principal and accrued interest may be forgiven to the extent loan proceeds are used for qualifying expenses as described in the CARES Act and applicable implementing guidance issued by the U.S. Small Business Administration under the PPP. We intend to use all or a substantial portion of the loan for designated qualifying expenses and to apply for forgiveness of all or a substantial portion of the loan in accordance with the terms of the PPP. No assurance can be given that we will obtain forgiveness of the loan in whole or in part. With respect to any portion of the loan that is not forgiven, the loan will be subject to customary provisions for a loan of this type, including customary events of default relating to, among other things, payment defaults and breaches of the note’s provisions.

We believe that our existing cash and cash equivalents balance will be sufficient to maintain our current operations considering our current financial condition, obligations, the proceeds of the PPP loan and other expected cash flows. If our circumstances change, however, we may require additional cash. If we require additional cash, we may attempt to raise additional capital through equity, equity-linked or debt financing arrangements. If we raise additional funds by issuing equity or equity-linked securities, the ownership of our existing stockholders will be diluted. If we raise additional financing by the incurrence of indebtedness, we could be subject to fixed payment obligations and could also be subject to restrictive covenants, such as limitations on our ability to incur additional debt, and other operating restrictions that could adversely impact our ability to conduct our business. If we are unable to raise additional needed funds, we may also take measures to reduce expenses to offset any shortfall.

### Cash Flow Analysis

Our cash flows from operating, investing and financing activities are summarized as follows:

*(in thousands)*

|  | Nine Months Ended September 30, 2020 | 2019 |
| --- | ---: | ---: |
| Net cash provided by operating activities | $42 | $74 |
| Net cash used in investing activities | $(66) | $(189) |
| Net cash provided by financing activities | $186 | $— |

#### Net Cash Provided by Operating Activities

For the nine months ended September 30, 2020, the $42 thousand in net cash provided by operating activities was primarily attributable to net income of $60 thousand plus adjustments for non-cash charges of $396 thousand, resulting in a net increase in cash of $456 thousand. This increase, however, was offset by changes in operating assets and liabilities that resulted in a net use of cash of $414 thousand, primarily related to increases in accounts receivable, inventories and prepaid expenses and other current assets, and decreases in lease liabilities and deferred income taxes, partially offset by increases in accounts payable, accrued liabilities and accrued income taxes.

For the nine months ended September 30, 2019, the $74 thousand in net cash provided by operating activities was primarily attributable to net loss of $94 thousand, adjusted for non-cash charges of $363 thousand, resulting in a net increase in cash of $269 thousand. This increase, however, was offset by changes in operating assets and liabilities that resulted in a net use of cash of $195 thousand, primarily related to increases in accounts receivable and inventories and decreases in accounts payable and lease liabilities, partially offset by decreases in prepaid expenses and other current assets and increases in accrued liabilities, accrued income taxes and deferred income taxes.

Accounts receivable increased from $730 thousand at December 31, 2019 to $924 thousand at September 30, 2020 due to timing of shipments and collections during the third quarter of 2020 as compared to the end of 2019. Many of our customers pay immediately and accounts receivable is generally related to the most recent shipments. Inventories increased from $927 thousand at December 31, 2019 to $963 thousand at September 30, 2020. Inventory balances will fluctuate at the end of any accounting period depending on the timing of materials purchases and product shipments. Prepaid expenses and other current assets increased from $330 thousand at September 30, 2019 to $497 thousand at September 30, 2020. Current liabilities increase from $687 thousand at December 31, 2019 to $1.1 million at September 30, 2020 primarily due to the PPP loan, accrued income taxes and increases in lease liabilities.

#### Net Cash Used in Investing Activities

Net cash used in investing activities of $66 thousand and $189 thousand for the nine months ended September 30, 2020 and 2019, respectively, primarily related to costs in securing patents on new products and processes developed thereunder and, in the 2019 period, capital expenditures for the continued investment in our R&D center in Singapore.

#### Net Cash Provided by Financing Activities

Net cash provided by financing activities for the nine months ended September 30, 2020 related to proceeds from the PPP loan. There were no financing activities during the nine months ended September 30, 2019.

### Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements.

## Controls and procedures

As filed, 2,575 characters.

### Evaluation of Disclosure Controls and Procedures

The phrase “disclosure controls and procedures” refers to controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934, as amended, or the Exchange Act, such as this Quarterly Report on Form 10-Q, is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the U.S. Securities and Exchange Commission, or SEC. Disclosure controls and procedures are also designed to ensure that such information is accumulated and communicated to our management, including our chief executive officer, or CEO, and chief financial officer, or CFO, as appropriate to allow timely decision regarding required disclosure.

Our management, with the participation of our CEO and CFO, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of September 30, 2020, the end of the period covered by this Quarterly Report on Form 10-Q. Based on such evaluation, our CEO and CFO had concluded that as of September 30, 2020, our disclosure controls and procedures were designed at a reasonable assurance level and were effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure.

### Changes in Internal Controls over Financial Reporting

There was no change in our internal control over financial reporting during the period ended September 30, 2020 that materially affected, or is reasonable likely to materially affect, our internal control over financial reporting.

### Limitations on Effectiveness of Controls and Procedures

In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.

## Risk factors

As filed, 584 characters.

This Quarterly Report on Form 10-Q contains forward-looking statements, which are subject to a variety of risks and uncertainties. Other actual results could differ materially from those anticipated in those forward-looking statements as a result of various factors, including those set forth in the risk factors relating to our business and common stock contained in Item 1A of our Amendment No. 2 to Registration Statement on Form 10 filed with the SEC on September 29, 2020. There have been no material changes to such risk factors during the three months ended September 30, 2020.

Filed Nov 13, 2020.
Source: SEC EDGAR, the filing index for accession 0001104659-20-124555. Last ingested by Listed: Nov 14, 2026, 19:46 ET. No prices; not investment advice.
